Al-Serwi, R.H.; Eladl, M.A.; El-Sherbiny, M.; Saleh, M.A.; Othman, G.; Alshahrani, S.M.; Alnefaie, R.; Jan, A.M.; Alnasser, S.M.; Albalawi, A.E.;
et al. Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid–Quercetin-Conjugated Silver Nanoparticles. Molecules 2023, 28, 4146.
https://doi.org/10.3390/molecules28104146
AMA Style
Al-Serwi RH, Eladl MA, El-Sherbiny M, Saleh MA, Othman G, Alshahrani SM, Alnefaie R, Jan AM, Alnasser SM, Albalawi AE,
et al. Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid–Quercetin-Conjugated Silver Nanoparticles. Molecules. 2023; 28(10):4146.
https://doi.org/10.3390/molecules28104146
Chicago/Turabian Style
Al-Serwi, Rasha H., Mohamed A. Eladl, Mohamed El-Sherbiny, Mohamed A. Saleh, Gamal Othman, Sultan M. Alshahrani, Rasha Alnefaie, Afnan M. Jan, Sulaiman M. Alnasser, Aishah E. Albalawi,
and et al. 2023. "Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid–Quercetin-Conjugated Silver Nanoparticles" Molecules 28, no. 10: 4146.
https://doi.org/10.3390/molecules28104146
APA Style
Al-Serwi, R. H., Eladl, M. A., El-Sherbiny, M., Saleh, M. A., Othman, G., Alshahrani, S. M., Alnefaie, R., Jan, A. M., Alnasser, S. M., Albalawi, A. E., Mohamed, J. M. M., & Menaa, F.
(2023). Targeted Drug Administration onto Cancer Cells Using Hyaluronic Acid–Quercetin-Conjugated Silver Nanoparticles. Molecules, 28(10), 4146.
https://doi.org/10.3390/molecules28104146
